Terns Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. Thanks for joining the 21st Annual Needham Healthcare Conference. My name is Joey Stringer; I'm one of the biotech analysts at Needham and Company. It's my pleasure to introduce our next presenting company, Terns Pharma. Joining us today from Terns is SVP, Chief Development Officer, Diana Chung. (Conference Instructions)
With that, we'll get started. I'll turn it over to Diana for the presentation.
Great. Thanks, Joey. Appreciate the introduction. Hello. My name is Diana Chung. I'm Chief Development Officer at Terns. I first wanted to thank the organizers of the Needham Healthcare Conference for allowing me the opportunity to present an update on Terns as well as our development program. For those in the audience, I would like to direct you to the Terns website to review our disclosure statements.
So Terns is a small biotech company based in the San Francisco Bay area, and we're focused on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |